SweetValueLab
Write for us

Equifax Inc. — Wall Street Analyst Estimates & Price Targets

EFX
NYSEIndustrialsConsulting ServicesCIK 0000033185equifax.comAbout EFX
Last close · Oct 16, 2026161.25−0.01 (−0.01%)
Market cap$18.9B

11 firms' latest targets, last 90 days: median $208.00 ($148.00–$245.00), 29% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$150$200$250NovJan 2026MarMayJulSep2025-10-22 · BMO Capital: $2452025-10-22 · Stifel: $2532025-12-08 · BMO Capital: $2342025-12-17 · Morgan Stanley: $2802026-02-04 · Morgan Stanley: $2442026-02-05 · RBC Capital: $2222026-02-05 · Needham: $2652026-02-05 · Stifel: $2352026-02-05 · RBC Capital: $2202026-02-05 · BMO Capital: $1952026-02-05 · Baird: $2502026-02-05 · UBS: $2302026-02-05 · Barclays: $2152026-02-06 · Goldman Sachs: $2082026-04-16 · Mizuho Securities: $2222026-04-23 · UBS: $2202026-06-16 · UBS: $2152026-06-18 · Wells Fargo: $2202026-06-26 · Goldman Sachs: $1732026-07-02 · Mizuho Securities: $2102026-07-21 · Goldman Sachs: $1822026-07-22 · Deutsche Bank: $2082026-07-22 · Needham: $2452026-07-22 · Wells Fargo: $2122026-07-22 · Morgan Stanley: $2252026-07-22 · Baird: $2322026-07-22 · Barclays: $2002026-07-22 · RBC Capital: $1942026-08-21 · Rothschild & Co Redburn: $2352026-09-08 · BNP Paribas Exane: $2452026-09-22 · Wells Fargo: $2002026-09-29 · Goldman Sachs: $1712026-09-30 · Credit Suisse: $1602026-10-02 · Goldman Sachs: $1482026-10-02 · Barclays: $1552026-10-16 · RBC Capital: $177
$150$200$250NovFebMayAug

Each firm's latest target

last 90 days · 11 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-16RBC Capital$177.00$194.00▼ 9%+10%+10%
2026-10-02Goldman Sachs$148.00$171.00▼ 13%+6%-8%
2026-10-02Barclays$155.00$200.00▼ 22%+11%-4%
2026-09-30Credit Suisse$160.00——+14%-1%
2026-09-22Wells Fargo$200.00$212.00▼ 6%+26%+24%
2026-09-08BNP Paribas Exane$245.00——+38%+52%
2026-08-21Rothschild & Co Redburn$235.00——+22%+46%
2026-07-22Deutsche Bank$208.00——+22%+29%
2026-07-22Needham$245.00$265.00▼ 8%+42%+52%
2026-07-22Morgan Stanley$225.00$244.00▼ 8%+30%+40%
2026-07-22Baird$232.00$250.00▼ 7%+34%+44%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$5.3B+3%$4.40-22%est. $5.3B+0%est. $6.6517
2024reported$5.7B+8%$4.84+10%est. $5.7B+0%est. $7.2617
2025reported$6.1B+7%$5.32+10%est. $6.1B+0%est. $7.6219
2026$6.7B+11%$8.52+12%$6.7B–$6.8B$8.15–$8.6618
2027$7.3B+8%$10.00+17%$7.0B–$7.5B$8.99–$10.5917
2028$8.0B+10%$12.10+21%$7.4B–$8.6B$11.97–$12.2114
2029$8.1B+1%$12.76+5%$7.7B–$8.3B$12.10–$13.318
2030$8.4B+5%$13.00+2%$8.1B–$8.7B$12.33–$13.5612
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.